Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Buy
8,721
+532
+6% +$24.6K 0.03% 270
2026
Q1
$401K Buy
8,189
+615
+8% +$28.6K 0.03% 304
2025
Q4
$330K Buy
7,574
+139
+2% +$6.34K 0.03% 342
2025
Q3
$335K Buy
7,435
+1,560
+27% +$68.5K 0.03% 336
2025
Q2
$255K Buy
5,875
+438
+8% +$19.5K 0.02% 337
2025
Q1
$251K Sell
5,437
-4,855
-47% -$203K 0.02% 389
2024
Q4
$387K Buy
10,292
+40
+0.4% +$1.55K 0.03% 353
2024
Q3
$416K Sell
10,252
-65
-0.6% -$2.44K 0.03% 317
2024
Q2
$357K Sell
10,317
-636
-6% -$23.5K 0.03% 333
2024
Q1
$412K Buy
10,953
+547
+5% +$19.5K 0.03% 328
2023
Q4
$374K Buy
+10,406
New +$401K 0.03% 340

Other funds holding EXC

Trust Point Inc's EXC Position: Q2 2026 in Review

Trust Point Inc increased its Exelon (EXC) stake by 6.5% in Q2 2026, buying an estimated $24.6K and bringing the position to 8,721 shares worth $407K. The position accounts for 0.03% of the portfolio, ranked #270.

Trust Point Inc first reported a position in EXC in Q4 2023 and has held it in 11 quarters since. The position peaked at $416K in Q3 2024. 1,287 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Trust Point Inc held 8,721 shares of Exelon worth $407K as of Q2 2026.
  • Trust Point Inc bought 532 Exelon shares in Q2 2026, an estimated $24.6K.
  • Exelon made up 0.03% of Trust Point Inc's portfolio in Q2 2026, its #270 holding.
  • Trust Point Inc first reported a position in Exelon in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Exelon position peaked at $416K in Q3 2024.
  • 1,287 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.